Wilson, J. C.Murray, L. J.Hughes, C. M.Black, A.Anderson, L. A.2020-03-232020-03-232013-03-19Wilson, J C, Murray, L J, Hughes, C M, Black, A & Anderson, L A 2013, 'Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer', British Journal of Cancer, vol. 108, no. 5, pp. 1178-1181. https://doi.org/10.1038/bjc.2013.730007-0920ORCID: /0000-0002-1000-3649/work/71090129https://hdl.handle.net/2164/13902Acknowledgements This research was supported by contracts from the Division of Cancer Prevention, National Cancer Institute; NIH, DHHS. We thank Drs Christine Berg and Philip Prorok, Division of Cancer Prevention, National Cancer Institute, the Screening Centre investigators and staff of the PLCO Cancer Screening Trial; Mr Tom Riley and staff, Information Management Services, Inc.; Ms Barbara O’Brien and staff, Westat, Inc. Most importantly, we acknowledge the study participants for their contributions to making this study possible.4154437engSDG 3 - Good Health and Well-beingaspirincohort studyhead and neck canceribuprofenRC0254 Neoplasms. Tumors. Oncology (including Cancer)OncologyCancer ResearchRC0254Journal article10.1038/bjc.2013.73http://www.scopus.com/inward/record.url?scp=84875468113&partnerID=8YFLogxK1085